MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0005251659524409713 | N/A |
Market Cap | $15.72K | N/A |
Shares Outstanding | 29.93M | N/A |
Employees | 33.00 | N/A |